The PSA Total Test measures the level of prostate-specific antigen in the blood, helping to screen for prostate cancer, monitor existing conditions, and evaluate treatment effectiveness.

Avoid vigorous activities and sexual activity for 48 hours before the test. Inform your doctor about any medications you are taking. No fasting is required.

Elevated PSA levels may suggest prostate inflammation, benign prostatic hyperplasia (BPH), or prostate cancer. Further tests may be required for a definitive diagnosis.

Results are typically available within 24 to 48 hours after the blood sample is collected.

Discuss the results with your healthcare provider to determine the next steps, which may include additional tests or a referral to a specialist for further evaluation.

Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.

Risks include infection, bleeding, urinary incontinence, changes in bladder function, and potential need for further treatments.